Your browser doesn't support javascript.
loading
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial.
Wei, Andrew H; Döhner, Hartmut; Sayar, Hamid; Ravandi, Farhad; Montesinos, Pau; Dombret, Hervé; Selleslag, Dominik; Porkka, Kimmo; Jang, Jun-Ho; Skikne, Barry; Beach, C L; Prebet, Thomas; Zhang, George; Risueño, Alberto; Ugidos, Manuel; See, Wendy L; Menezes, Daniel; Roboz, Gail J.
Afiliação
  • Wei AH; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Victoria, Australia.
  • Döhner H; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
  • Sayar H; Ulm University Hospital, Ulm, Germany.
  • Ravandi F; Indiana University Cancer Center, Indianapolis, Indiana, USA.
  • Montesinos P; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dombret H; Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Selleslag D; Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Porkka K; Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.
  • Jang JH; AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium.
  • Skikne B; HUS Comprehensive Cancer Center, Hematology Research Unit Helsinki and iCAN Digital Precision Cancer Center Medicine Flagship, University of Helsinki, Helsinki, Finland.
  • Beach CL; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Prebet T; University of Kansas Cancer Center, Kansas City, Kansas, USA.
  • Zhang G; Bristol Myers Squibb, Summit, New Jersey, USA.
  • Risueño A; Bristol Myers Squibb, Summit, New Jersey, USA.
  • Ugidos M; Bristol Myers Squibb, Summit, New Jersey, USA.
  • See WL; Bristol Myers Squibb, Summit, New Jersey, USA.
  • Menezes D; BMS Center for Innovation and Translational Research Europe (CITRE, a Bristol-Myers Squibb Company), Seville, Spain.
  • Roboz GJ; BMS Center for Innovation and Translational Research Europe (CITRE, a Bristol-Myers Squibb Company), Seville, Spain.
Am J Hematol ; 98(4): E84-E87, 2023 04.
Article em En | MEDLINE | ID: mdl-36655608
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2023 Tipo de documento: Article